SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
Open Access
- 1 November 2021
- journal article
- review article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 6191-6221
Abstract
Coronavirus disease-2019 (COVID-19) is asymptomatic in most cases, but it is impartible and fatal in fragile and elderly people. Heretofore, more than four million people succumbed to COVID-19, while it spreads to every part of the globe. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) induces various dysfunctions in many vital organs including the thyroid by utilizing ACE2 as a receptor for cellular entry. Emerging reports clearly show the involvement of SARS-CoV-2 in diverse thyroid disorders. Thus, this review article aims to review comprehensively all the recent developments in SARS-CoV-2-induced pathogenesis of thyroid diseases. The review briefly summarizes the recent key findings on the mechanism of SARS-CoV-2 infection, the role of ACE2 receptor in viral entry, SARS-CoV-2-activated molecular signaling in host cells, ACE2 expression in the thyroid, cytokine storm, and its vital role in thyroid dysfunction and long-COVID in relation to thyroid and autoimmunity. Further, it extensively discusses rapidly evolving knowledge on the potential part of SARS-CoV-2 in emerging various thyroid dysfunctions during and post-COVID-19 conditions which include subacute thyroiditis, Graves’ diseases, Hashimoto’s thyroiditis, thyrotoxicosis, and other recent advances in further discerning the implications of this virus within thyroid dysfunction. Unraveling the pathophysiology of SARS-CoV-2-triggered thyroid dysfunctions may aid pertinent therapeutic options and management of these patients in both during and post-COVID-19 scenarios.Keywords
This publication has 158 references indexed in Scilit:
- New Insights toward the Acute Non-Thyroidal Illness SyndromeFrontiers in Endocrinology, 2012
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS)This paper is one of a selection of papers published in this special issue entitled “Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine” and has undergone the Journal's usual peer review process.Biochemistry and Cell Biology, 2010
- Development of Hashimoto's Thyroiditis After Subacute Thyroiditis: An Unusual PatientThyroid®, 2009
- Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart FailureJACC, 2008
- The emerging role of ACE2 in physiology and diseaseThe Journal of Pathology, 2007
- The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune diseaseClinical and Experimental Immunology, 2007
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- Cytokine dysregulation as a mechanism of graft versus host diseaseCurrent Opinion in Immunology, 1993